Effect of lower doses of conjugated equine estrogens with and without medroxyprogesterone acetate on bone in early postmenopausal women.
about
Hormone therapy for preventing cardiovascular disease in post-menopausal womenHormone therapy for sexual function in perimenopausal and postmenopausal womenEstrogen and progestogen use in postmenopausal women: July 2008 position statement of The North American Menopause Society.Postmenopausal syndromeControversies in osteoporosis management: antiresorptive therapy for preventing bone loss: when to use one or two antiresorptive agents?Advances in the treatment of menopausal symptoms.Tissue selective estrogen complex combinations with bazedoxifene/conjugated estrogens as a model.Conjugated estrogens for the treatment of menopausal symptoms: a review of safety data.Negative spinal bone mineral density changes and subclinical ovulatory disturbances--prospective data in healthy premenopausal women with regular menstrual cycles.Effect of high-dose isoflavones on cognition, quality of life, androgens, and lipoprotein in post-menopausal women.Flaxseed does not antagonize the effect of ultra-low-dose estrogen therapy on bone mineral density and biomechanical bone strength in ovariectomized rats.Effects of Combination Therapy of Alendronate and Hormonal Therapy on Bone Mineral Density in Postmenopausal Korean Women: Multicenter, Randomized Controlled Clinical Trial.Female reproductive system and bone.American Association of Clinical Endocrinologists Medical Guidelines for Clinical Practice for the diagnosis and treatment of postmenopausal osteoporosisRevisiting estrogen: efficacy and safety for postmenopausal bone health.Progesterone and bone: actions promoting bone health in women.Prevention and treatment of postmenopausal osteoporosis.Effect of transdermal estrogen therapy on bone mineral density in postmenopausal korean women.Indications of clinical and genetic predictors for aromatase inhibitors related musculoskeletal adverse events in Chinese Han women with breast cancer.Comparing therapies for postmenopausal osteoporosis prevention and treatment.Role of the nonhuman primate for research related to women's health.Hormone replacement therapy and the prevention of postmenopausal osteoporosis.Management of age-related osteoporosis and prevention of associated fractures.Hormonal Add-Back Therapy for Females Treated With Gonadotropin-Releasing Hormone Agonist for Endometriosis: A Randomized Controlled Trial.Effects of low-dose hormone therapy on menopausal symptoms, bone mineral density, endometrium, and the cardiovascular system: a review of randomized clinical trials.Attitudes toward hormone replacement therapy in the new millennium: university physicians' and patients' perspectives.Cancer treatment-related bone loss: a review and synthesis of the literature.Hormone therapy in the WHI era.Hormone therapy: maximizing the benefits.Issues concerning the use of hormone replacement therapy and risk of fracture: a population-based, nested case-control study.Effects of estrogen with micronized progesterone on cortical and trabecular bone mass and microstructure in recently postmenopausal womenOsteoporosis and periodontal disease.The HRT misuse and osteoporosis epidemic: a possible future scenario.Care of the menopausal patient: a nurse practitioner's view.American Association of Clinical Endocrinologists Medical Guidelines for Clinical Practice for the diagnosis and treatment of postmenopausal osteoporosis: executive summary of recommendations.Italian position statement on hormone replacement therapy following the National Conference on Menopause and Hormone Replacement Therapy, Villa Tuscolana, Frascati (Rome), May 8-9, 2007.Profile of bazedoxifene/conjugated estrogens for the treatment of estrogen deficiency symptoms and osteoporosis in women at risk of fractureThe tissue selective estrogen complex: a promising new menopausal therapyWomen's Health Initiative clinical trials: interaction of calcium and vitamin D with hormone therapyA new approach to menopausal therapy: the tissue selective estrogen complex.
P2860
Q24187326-5A2BE65F-CC6F-4CF1-8332-D2E406283B19Q24202201-C1FB7501-A416-4BB8-BF08-CCA6392CD679Q24658109-BE46BE0B-2308-46CD-BE37-5CD9E4907D84Q26795412-6CFAC633-EA0C-4415-92FC-28BC8730F86AQ27026510-6B063550-E8D2-4E2B-A64C-9999F1EAA633Q30448720-BB1814D7-68B9-4EFA-A0B2-6AB65DF1B2FBQ30456770-99C7C109-35CD-4074-8A11-512C23F6E247Q30659580-B0CE9784-1BF0-4F8E-AE1F-17B355D39349Q30701325-B53CC57D-2585-40F7-AAD9-92355596A160Q33438267-ED12D3E0-F96B-483B-8064-7D41BB617C03Q33524436-3420875A-798A-4A21-829F-471F2AA41C8EQ33661422-618B39DD-B0F1-4D2B-8E47-23242668BAB4Q34142868-FBE9D6F7-37D7-49BA-A36B-9586CF9AC23CQ34158441-FFC289C7-570D-4BB4-9E80-399035D3F0CFQ34211142-1D619B43-C5DD-44EB-AE68-95481F6EBC2AQ34261512-1D3C7AAD-7B61-4009-8727-2145F8B687D3Q34296614-5802EC42-5416-4093-83ED-49F49A0C8C88Q34863717-E44A0E47-3C84-4BC5-9D9C-09F92682FA55Q34873249-C666A1DB-D924-4570-B4B7-0F43B26EE793Q35112397-3FF069FD-EC14-4A77-A2C3-D6702CE20535Q35757584-C3C4B70C-BF14-4CF7-BC8D-73188167C950Q35903603-5F346793-50E6-4112-B65C-ACDD5F7BED72Q35919125-ADAF08AB-63AA-4348-AF03-069F6CF85300Q35984350-54624F0E-B6EC-45FC-8972-F8438E517EF9Q36086159-3485D35F-0399-4435-9E31-35B8138C8C1EQ36278168-16E3B9BD-CC9C-425B-8CFB-E650543EC95EQ36410640-C3612930-F3D0-42BA-A9AC-A48D30E7B74DQ36459544-2180F16D-C161-4278-81B2-62A9455557A1Q36533644-C52457B7-18BC-4E23-9CC2-2D68319B5FA1Q36535984-EC88C491-C2C4-4BEC-8AD3-334BA069053EQ36589366-F786A2D8-DB92-45B0-BB40-AC5736FC963AQ36809161-D0CC7926-60A6-4BB9-8683-69EF8A0F7BA3Q36892314-2AB08D5C-3355-485E-BF92-DA8B505FD184Q36892860-0A6051CA-8262-4F78-9477-D6FCB03CCCBDQ36959809-77C1BDA9-696F-428F-86E5-995FFE19262EQ36970351-44249AB9-7CBB-4F0F-B1C6-B62FE37F5B3BQ37048294-C850AB92-9DC9-41FC-BB05-C2FE6FB6CF4BQ37277298-A64B633E-9677-4CE0-A46D-3CA9A5910B09Q37315529-3C6D6B13-B119-437C-98DA-82CA462796CAQ37352516-933F0866-0FCD-41BB-872C-52DBEE23AAE7
P2860
Effect of lower doses of conjugated equine estrogens with and without medroxyprogesterone acetate on bone in early postmenopausal women.
description
2002 nî lūn-bûn
@nan
2002 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Effect of lower doses of conju ...... in early postmenopausal women.
@ast
Effect of lower doses of conju ...... in early postmenopausal women.
@en
type
label
Effect of lower doses of conju ...... in early postmenopausal women.
@ast
Effect of lower doses of conju ...... in early postmenopausal women.
@en
prefLabel
Effect of lower doses of conju ...... in early postmenopausal women.
@ast
Effect of lower doses of conju ...... in early postmenopausal women.
@en
P2093
P356
P1476
Effect of lower doses of conju ...... in early postmenopausal women.
@en
P2093
J Christopher Gallagher
James H Pickar
Michael Kleerekoper
Robert Lindsay
P304
P356
10.1001/JAMA.287.20.2668
P407
P577
2002-05-01T00:00:00Z